ResMed Inc. Overview
Pro stress-test →ResMed develops cloud-connected medical devices and software solutions that treat sleep apnea, COPD, and other respiratory disorders for home and clinical use. By enabling better care, ResMed improves quality of life, reduces the impact of chronic disease, and lowers costs for consumers and healthcare systems in more than 140 countries.
Strategic Profile
Pro stress-test →The company's strategy focuses on transforming healthcare in the home with hardware, software and solutions that people love. ResMed's EPS grew at a 14.2% compounded annual growth rate over five years, higher than its 11.8% annualized revenue growth, demonstrating strong profitability expansion. With a notable 66.4% Return on Invested Capital, ResMed demonstrates management's strong skill in using capital for high-return growth, indicating a lasting competitive edge.
Competitive Landscape
Pro stress-test →ResMed operates in the digital health and cloud-connected medical device space for treating sleep apnea, COPD, and other chronic diseases. The company faces competition from other respiratory device manufacturers and digital health software providers, but maintains leadership through its integrated portfolio spanning devices, masks, and cloud-based care management platforms across multiple geographic markets.
Industry Context
ResMed Inc. operates in Medical Devices & Digital Health Technology.
Key facts
Founded: 1989 · Headquarters: San Diego, United States · Employees: 32000 · Revenue: $5.4B · Market cap: $36.78B